BRIEF-COUR Pharmaceuticals Secures FDA Clearance of IND Application for CNP-103 in Type 1 Diabetes
Feb 4 (Reuters) -
Source text: ID:nGNXb1rbjN
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.